Engaging Innovation | Friends of Cancer Research

Engaging Innovation

Featured Post

October 10, 2019

Despite criticism, FDA is doing what is right by rare cancer patients

On October 1, the first-ever Rare Cancer Day, an awareness day highlighting the challenges people living with rare cancers face and emphasizing the importance of early diagnosis, was marked by thousands nationwide. Cancer is not a singular disease but, rather, many diseases, of which several are rare. One in 5...
More Posts

Recent Posts

No Results With Current Filter Choices

22nd Annual Cancer Leadership Awards Reception

This year's awardees at the 22nd Annual Cancer Leadership Awards Reception From L-R: Dr. Anthony Fauci, Dr. Richard Klausner September 21, 2018The Hay-Adams800 16th St NW, Washington, DC 20006   On September 21, 2018, Friends of Cancer Research (Friends) hosted the 22nd Annual Cancer Leadership Awards Reception. The yearly event brings together leaders in...

A Plea to Make Cancer Clinical Trials More Patient Friendly

Jim Omel is a myeloma patient and a cancer research advocate. He spoke at the 2017 Friends of Cancer Research Annual Meeting and was an author of the panel 2 whitepaper, Data Generation to Support Cross-Labeling of Indications for Combination Products. Below are his abridged remarks from the meeting. To...

Keeping Patients at the Forefront of Our Work

I was 18 when my life was turned upside down by cancer. My mother was diagnosed with a highly aggressive malignancy after a colonoscopy due to a flair-up of Crohn’s disease. She spent the next two months in the hospital after the surgery to remove the malignancy left her near...

Ellen Sigal Talks About Collaboration in Lung-MAP

Friends of Cancer Research Chairperson & Founder, Ellen Sigal, discusses the structure and promise of the Lung-MAP clinical trial.

My Story: Stephanie Haney

Stephanie and her family were shocked by her diagnosis. She had no risk factors or family history. With the help of newly available treatments, such as breakthrough therapies, she has defied the odds.

My Story: Stephanie Haney

Stephanie and her family were shocked by her diagnosis. She had no risk factors or family history. With the help of newly available treatments, such as breakthrough therapies, she has defied the odds.

My Story: Stephanie Haney

Stephanie and her family were shocked by her diagnosis. She had no risk factors or family history. With the help of newly available treatments, such as breakthrough therapies, she has defied the odds.

Back to Top